NextPharma Oy
FDA inspection history in TAMPERE, Finland, 2022
- 1
- Form 483
Every document, by year
- Form 483
2022: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2022One Form 483, at TAMPERE, Finland.
Cited most
Across all NextPharma Oy observations on file
- 21 CFR 211.113Control of microbiological contamination2
- 21 CFR 211.110Sampling and testing of in-process materials and drug products1
- 21 CFR 211.42Design and construction features1
- 21 CFR 211.58Maintenance1
- 21 CFR 211.67Equipment cleaning and maintenance1
The complete NextPharma Oy file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
TAMPERE, Finland
One Form 483 · 2022 · 6 observations
Latest: Form 483, Sep 6, 2022 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2022-09-06 | 483 Form 483 | TAMPERE, Finland | 6 | $99 |
Investigators on these documents
FEI number 3016974567 · most recent document Sep 6, 2022
About NextPharma Oy
How many FDA Form 483s has NextPharma Oy received?
FDA Intel has 1 Form 483 on file for NextPharma Oy; the most recent is dated Sep 6, 2022.
When was NextPharma Oy last inspected by FDA?
The most recent FDA inspection document on file for NextPharma Oy is a Form 483 dated Sep 6, 2022, for the site in TAMPERE, Finland.
What did FDA cite at NextPharma Oy?
The regulations cited most in the observations on file for NextPharma Oy are 21 CFR 211.113 (Control of microbiological contamination), 2 times; 21 CFR 211.110 (Sampling and testing of in-process materials and drug products), 1 time; 21 CFR 211.42 (Design and construction features), 1 time.